ProfileGDS4459 / ENSG00000162078
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 46% 26% 49% 45% 33% 35% 42% 39% 39% 40% 36% 35% 44% 29% 42% 38% 32% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 14.2946
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 23.6526
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 34.3249
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 44.3445
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 53.7633
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 63.8635
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 74.0942
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 83.9239
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 93.9339
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 104.0540
GSM623474group B, liver allograft wedge biopsie placebo treatment 13.8236
GSM623475group B, liver allograft wedge biopsie placebo treatment 23.7335
GSM623476group B, liver allograft wedge biopsie placebo treatment 34.1844
GSM623477group B, liver allograft wedge biopsie placebo treatment 43.7429
GSM623478group B, liver allograft wedge biopsie placebo treatment 54.0242
GSM623479group B, liver allograft wedge biopsie placebo treatment 64.0138
GSM623480group B, liver allograft wedge biopsie placebo treatment 73.8232